Bristol-Myers Squibb Brasil S.A.
- A10 - Antidiabéticos
- FORXIGA film-coated tablet 10 mg
- FORXIGA film-coated tablet 5 mg
- KOMBIGLYZE XR prolonged-release tablet 1000 mg+2.5 mg
- KOMBIGLYZE XR prolonged-release tablet 1000 mg+5 mg
- KOMBIGLYZE XR prolonged-release tablet 500 mg+5 mg
- ONGLYZA film-coated tablet 2.5 mg
- ONGLYZA film-coated tablet 5 mg
- XIGDUO XR prolonged-release tablet 1 000 mg+10 mg
- XIGDUO XR prolonged-release tablet 1 000 mg+5 mg
- B01 - Agentes antitrombóticos
- COUMADIN tablet 1 mg
- COUMADIN tablet 2.5 mg
- COUMADIN tablet 5 mg
- J01 - Antibacterianos para uso sistémico
- CEFEPIMA BMS powder for solution for injection 1 g
- CEFEPIMA BMS powder for solution for injection 2 g
- CEFEPIMA BMS powder for solution for injection 500 mg
- J05 - Antivirales de uso sistémico
- BARACLUDE film-coated tablet 0.5 mg
- L01 - Antineoplásicos
- CITOSTAL capsule, hard 10 mg
- CITOSTAL capsule, hard 40 mg
- HYDREA capsule, hard 500 mg
- MITOCIN powder for solution for injection 5 mg
- OPDIVO concentrate for solution for infusion 100 mg/10 ml
- OPDIVO concentrate for solution for infusion 40 mg/4 ml
- SPRYCEL film-coated tablet 100 mg
- SPRYCEL film-coated tablet 20 mg
- SPRYCEL film-coated tablet 50 mg
- TAXOL concentrate for solution for infusion 100 mg/16.7 ml
- TAXOL concentrate for solution for infusion 30 mg/5 ml
- TAXOL concentrate for solution for infusion 300 mg/50 ml
- YERVOY solution for injection 200 mg/40 ml
- YERVOY solution for injection 50 mg/10 ml
- L02 - Terapia endocrina
- MEGESTAT tablet 160 mg
- L04 - Inmunosupresores
- ORENCIA powder for solution for infusion 250 mg
- ORENCIA PREFILLED SYRINGE solution for injection 125 mg/ml
- R01 - Preparaciones nasales
- NALDECON DIA tablet 800 mg+20 mg
- NALDECON PACK tablet 400 mg/400 mg+20 mg - 400 mg+4 mg
- NALDECON tablet 400 mg+20 mg - 400 mg+4 mg